JPRN-UMIN000037812
Completed
未知
Evaluation of HE4 in ovarian cancer - Evaluation of HE4 in ovarian cancer
ihon University Hospital0 sites59 target enrollmentAugust 27, 2019
ConditionsOvarian cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Ovarian cancer
- Sponsor
- ihon University Hospital
- Enrollment
- 59
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Gynecologic malignant tumor cases other than ovarian cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
HE4 as a Relapse Biomarker in Ovarian CancersOvarian CarcinomaNCT02595281Institut de Cancérologie de Lorraine90
Unknown
Not Applicable
Serum Biomarker HE4 During IVF TreatmentIVF TreatmentHuman Epididymal Secretory Protein E4NCT01576744Turku University Hospital20
Completed
Not Applicable
Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian CancerMetastatic Ovarian CancerNCT01768156Institut du Cancer de Montpellier - Val d'Aurelle101
Completed
Not Applicable
Evaluation of HE4 and CA125 serum markers to improve the risk determination of ovarian cancer in Malaysian womeOvarian cancerCancerMalignant neoplasm of ovaryISRCTN45238573Abbott Laboratories (Singapore)600
Unknown
Not Applicable
The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal CancerOvarian NeoplasmsNCT02687321Brno University Hospital150